Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Bladder Cancer

Free Subscription Articles published in Urol Int Retrieve available abstracts of 77 articles: HTML format

Single Articles

March 2024
1. DUAN H, Deng Z, Zou J, Zhang G, et al
   The efficacy and safety of Hyperthermia intravesical chemotherapy in the treatment non-muscle invasive bladder cancer:A meta analysis.
   Urol Int. 2024 Mar 20. doi: 10.1159/000538373.
   PubMed     Abstract available
   
   
   January 2024
2. REIKE MJ, Reicherz A, Tully KH, Bahlburg H, et al
   An empirical survey on the adaption of neoadjuvant chemotherapy in bladder cancer.
   Urol Int. 2024 Jan 19. doi: 10.1159/000536321.
   PubMed     Abstract available
   
   
   
3. BANEK S, Hoeh B, Cano Garcia C, Koll F, et al
   Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New Therapies.
   Urol Int. 2024;108:1-8.
   PubMed     Abstract available
   
   
   
4. VOLZ Y, Trappmann R, Ebner B, Eismann L, et al
   Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk?
   Urol Int. 2024;108:42-48.
   PubMed     Abstract available
   
   
   
5. GARAZ R, Stuhler V, Stenzl A, Rottscholl R, et al
   Hemangioma of the Urinary Bladder: A Brief Narrative Review of Their Diagnosis, Histology, and Treatment Options.
   Urol Int. 2024;108:83-88.
   PubMed     Abstract available
   
   
   
6. WALACH MT, Nitschke K, Gross-Weege M, Grosshans J, et al
   Cyclin A2 Expression as Predictive Biomarker in Muscle-Invasive Upper Tract Urothelial Carcinoma.
   Urol Int. 2024;108:128-136.
   PubMed     Abstract available
   
   
   December 2023
7. GUO Y, Li C, Zhang S, Zhu G, et al
   U-Net-Based Assistive Identification of Bladder Cancer: A Promising Approach for Improved Diagnosisc.
   Urol Int. 2023 Dec 11. doi: 10.1159/000535652.
   PubMed     Abstract available
   
   
   November 2023
8. GUO L, Zhang T, Taisheng L, Chen J, et al
   Laparoscopic Radical Cystectomy With Ileal Orthotopic Neobladder for Bladder Cancer: Current Indications and Outcomes.
   Urol Int. 2023 Nov 23. doi: 10.1159/000535032.
   PubMed     Abstract available
   
   
   September 2023
9. CHEN Z
   The Role of Specificity Protein 1 (SP1) in Bladder Cancer Progression through PTEN-Mediated AKT/mTOR Pathway.
   Urol Int. 2023 Sep 4:1-9. doi: 10.1159/000532128.
   PubMed     Abstract available
   
   
   August 2023
10. JIAO H, Wang L, Zhou X, Wu J, et al
    Prognostic Ability of Nutritional Indices for Outcomes of Bladder Cancer: A Systematic Review and Meta-Analysis.
    Urol Int. 2023 Aug 29:1-9. doi: 10.1159/000531884.
    PubMed     Abstract available
    
    
    June 2023
11. DU J, Zhan H, Chen J, Wang J, et al
    The Influence of Preoperative Hydronephrosis on the Prognosis after Radical Cystectomy among Patients with Different Pathological Stages of Bladder Cancer.
    Urol Int. 2023 Jun 2:1-8. doi: 10.1159/000531080.
    PubMed     Abstract available
    
    
    March 2023
12. FU Y, Liu K, Jiang X, Zhao L, et al
    Hsa_circ_0008035 Knockdown Inhibits Bladder Cancer Progression through miR-1184/RAP2B Axis.
    Urol Int. 2023 Mar 23:1-14. doi: 10.1159/000527873.
    PubMed     Abstract available
    
    
    February 2023
13. BOLAT D, Baltaci S, Akgul M, Karabay E, et al
    Predictive Role of the Systemic Immune Inflammation Index for Intravesical BCG Response in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer.
    Urol Int. 2023 Feb 21:1-7. doi: 10.1159/000528740.
    PubMed     Abstract available
    
    
    January 2023
14. FITOUSSI O, Roche JB, Riviere J, Wallerand H, et al
    Accuracy of FDG-PET/CT for Response Evaluation of Muscle-Invasive Bladder Cancer following Neoadjuvant or Induction Chemotherapy.
    Urol Int. 2023 Jan 19:1-7. doi: 10.1159/000528524.
    PubMed     Abstract available
    
    
    
15. TACHIBANA T, Ikeda M, Shimura S, Amano N, et al
    Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus Calmette-Guerin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and Treat Carcinoma in situ: A Multi-Institutional Retrospective Study.
    Urol Int. 2023 Jan 16:1-9. doi: 10.1159/000527718.
    PubMed     Abstract available
    
    
    
16. KORKES F, Timoteo F, Baccaglini W, Glina F, et al
    Postoperative Mortality Rate after Radical Cystectomy: A Systematic Review of Epidemiologic Series.
    Urol Int. 2023;107:96-104.
    PubMed     Abstract available
    
    
    
17. ZANG Z, Kesavan NR, Esuvaranathan K
    UBC(R)Rapid Is Sensitive in Detecting High-Grade Bladder Urothelial Carcinoma and Carcinoma in situ in Asian Population.
    Urol Int. 2023;107:29-34.
    PubMed     Abstract available
    
    
    
18. SCHNEIDEWIND L, Drager DL, Rossberg V, Nolting J, et al
    Prospective Evaluation of Health-Related Quality of Life in Patients with Metastatic Urothelial Carcinoma Undergoing Immunotherapy with Pembrolizumab: Symptom Burden Can Predict Survival.
    Urol Int. 2023;107:80-86.
    PubMed     Abstract available
    
    
    
19. MICHAEL KGFT, Ravindranath N, Michael S, German A, et al
    Optimizing Upper-Tract Imaging for Non-Visible Haematuria.
    Urol Int. 2023;107:23-28.
    PubMed     Abstract available
    
    
    
20. ZHANG Y, Ding H, Zhang Y, Tian J, et al
    Is Anti-Reflux Anastomosis an Advantage in an Orthotopic Ileal Neobladder? A Systematic Review and Meta-Analysis.
    Urol Int. 2023;107:1-14.
    PubMed     Abstract available
    
    
    
21. EISMANN L, Bohn L, Buchner A, Casuscelli J, et al
    Age and ECOG Performance Status as Predictors of Survival of Patients with Upper Urinary Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.
    Urol Int. 2023;107:72-79.
    PubMed     Abstract available
    
    
    
22. HAAS M, Knobloch C, Mayr R, Gierth M, et al
    Short-Term and Long-Term Morbidity after Radical Cystectomy in Patients with NMIBC and Comparison with MIBC: Identifying Risk Factors for Severe Short-Term Complications.
    Urol Int. 2023;107:246-256.
    PubMed     Abstract available
    
    
    
23. MEYER HJ, Wienke A, Zamsheva M, Surov A, et al
    Low Skeletal Muscle Mass Predicts Relevant Outcomes in Palliative Urological Oncology: A Systematic Review and Meta-Analysis.
    Urol Int. 2023;107:219-229.
    PubMed     Abstract available
    
    
    
24. CHEN S, Gao Y, Chen F, Wang TB, et al
    ANLN Serves as an Oncogene in Bladder Urothelial Carcinoma via Activating JNK Signaling Pathway.
    Urol Int. 2023;107:310-320.
    PubMed     Abstract available
    
    
    
25. HAEUSER L, Marchese M, Noldus J, Kibel AS, et al
    Association between Operative Time and Short-Term Radical Cystectomy Complications.
    Urol Int. 2023;107:273-279.
    PubMed     Abstract available
    
    
    
26. GRUNE B, Menold H, Lenhart M, Muhlbauer J, et al
    Patient Compliance in Assessing Electronic Patient-Reported Outcome Measures after Urologic Surgery.
    Urol Int. 2023;107:280-287.
    PubMed     Abstract available
    
    
    
27. BOLENZ C, Kunath F, Zengerling F, Wezel F, et al
    Increasing Biomarker Guidance in the Treatment of Urothelial Carcinoma: Systematic Review of International Clinical Trials.
    Urol Int. 2023;107:480-488.
    PubMed     Abstract available
    
    
    
28. GRUNE B, Kowalewski KF, Weiss C, Neuberger M, et al
    Predicting Complexity in Transurethral Resection of Bladder Tumours: External Validation and Modification of the Bladder Complexity Score.
    Urol Int. 2023;107:583-590.
    PubMed     Abstract available
    
    
    
29. WU YL, Li ZQ, Wu AM
    The Misdiagnosis of Intravesical Ectopic Prostatic Tissue as a Tumor.
    Urol Int. 2023;107:738-741.
    PubMed     Abstract available
    
    
    
30. STRUCK JP, Ozimek T, Schnoor M, Offermann A, et al
    The Role of Urine and Washing Cytology in Primary Transurethral Resection of Bladder Tumours.
    Urol Int. 2023;107:792-800.
    PubMed     Abstract available
    
    
    
31. BOKARICA P, Alfirevic M, Hrkac A, Glas AM, et al
    Letter to the Editor regarding the Article "Postoperative Mortality Rate after Radical Cystectomy: A Systematic Review of Epidemiologic Series".
    Urol Int. 2023;107:839-840.
    PubMed    
    
    
    
32. SHEN C, Zhang DL, Cheng XL, Zhang WC, et al
    Urological Tumor: A Narrative Review of Tertiary Lymphatic Structures.
    Urol Int. 2023;107:841-847.
    PubMed     Abstract available
    
    
    
33. YUAN P, Li X, Yuan Y, Xu P, et al
    Successful Kidney-Sparing Systemic Therapy for a High-Risk Ureteral Carcinoma Case.
    Urol Int. 2023;107:895-898.
    PubMed     Abstract available
    
    
    
34. WANG C, Yu H, Fu W, Chen G, et al
    Transurethral Hem-o-lok Clip Ligation of the Distal Ureter in Retroperitoneal Laparoscopic Radical Nephroureterectomy.
    Urol Int. 2023;107.
    PubMed     Abstract available
    
    
    
35. TULONE G, Pavan N, Giannone S, Abrate A, et al
    Double-Layered Hand-Sewn versus Stapled Intestinal Anastomosis in Patients Who Underwent Ileal Urinary Diversion in Radical Cystectomy: A Comparative and Cost Effective Study.
    Urol Int. 2023;107.
    PubMed     Abstract available
    
    
    June 2022
36. PAREEK T, Parmar K, Sharma AP, Kumar S, et al
    Quality of Life, Efficacy, and Safety of Sequential Intravesical Gemcitabine + Docetaxel versus BCG for Non-Muscle Invasive Urinary Bladder Cancer: A Pilot Study.
    Urol Int. 2022 Jun 2:1-7. doi: 10.1159/000524098.
    PubMed     Abstract available
    
    
    February 2022
37. KAMECKI H, Debowska M, Nyk L, Przewor A, et al
    The Clinical Features of Incidentally Diagnosed Urothelial Bladder Cancer: A Retrospective Data Analysis.
    Urol Int. 2022 Feb 11:1-8. doi: 10.1159/000521684.
    PubMed     Abstract available
    
    
    
38. VOLZ Y, Pfitzinger PL, Eismann L, Ebner B, et al
    Prognostic Value of Pretreatment Inflammatory Markers in Patients Receiving Radical Cystectomy for Urothelial Bladder Cancer: Does Age Matter?
    Urol Int. 2022 Feb 8:1-8. doi: 10.1159/000521829.
    PubMed     Abstract available
    
    
    
39. WEINHOLD P, Jokisch F, Schulz GB, Buchner A, et al
    Clinical Implication of Borderline CT-Morphological Metastatic Spread in Bladder Cancer: What You See Is Not Always What You Got.
    Urol Int. 2022 Feb 3:1-10. doi: 10.1159/000521857.
    PubMed     Abstract available
    
    
    January 2022
40. LANNES F, Walz J, Maubon T, Rybikowski S, et al
    Enhanced Recovery after Surgery for Radical Cystectomy Decreases Postoperative Complications at Different Times.
    Urol Int. 2022;106:171-179.
    PubMed     Abstract available
    
    
    
41. SHAO G, Xu C, Liu J, Li X, et al
    Clinical, Pathological, and Prognostic Analysis of Urachal Carcinoma.
    Urol Int. 2022;106:199-208.
    PubMed     Abstract available
    
    
    
42. LIU Z, Zhang P, Wang H, Zheng B, et al
    Raman Spectrum-Based Diagnosis Strategy for Bladder Tumor.
    Urol Int. 2022;106:109-115.
    PubMed     Abstract available
    
    
    
43. CHEN H, Wang M, Weng T, Wei Y, et al
    Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
    Urol Int. 2022;106:186-194.
    PubMed     Abstract available
    
    
    
44. ADAMCZYK P, Poblocki P, Kadlubowski M, Ostrowski A, et al
    Complication Rate after Radical Cystectomy Depends on the Surgical Technique and Patient's Clinical Status.
    Urol Int. 2022;106:163-170.
    PubMed     Abstract available
    
    
    
45. LEE J, Suh J, Jeong CW, Kwak C, et al
    Efficacy of the Treatment of Intraperitoneal Bladder Perforation during Transurethral Resection of Bladder Tumor with the Urethral Catheter Alone: Retrospective Analysis of over 15 Years Using the Clinical Data Warehouse System.
    Urol Int. 2022;106:138-146.
    PubMed     Abstract available
    
    
    
46. GROBET-JEANDIN E, Wirth GJ, Benamran D, Dupont A, et al
    Substaging of pT1 Urothelial Bladder Carcinoma Predicts Tumor Progression and Overall Survival.
    Urol Int. 2022;106:130-137.
    PubMed     Abstract available
    
    
    
47. GRAFFEILLE V, Verhoest G, Gryn A, Kammerer-Jacquet SF, et al
    Complete Transurethral Resection before Radical Cystectomy May Improve Oncological Outcomes.
    Urol Int. 2022;106:122-129.
    PubMed     Abstract available
    
    
    
48. STOKKEL LE, van de Kamp MW, Schaake EE, Boellaard TN, et al
    Robot-Assisted Partial Cystectomy versus Open Partial Cystectomy for Patients with Urachal Cancer.
    Urol Int. 2022;106:840-847.
    PubMed     Abstract available
    
    
    
49. NIENTIEDT M, Waldbillig F, Stroop F, Nuhn P, et al
    Upper Tract Urinary Cancer Recurrence after Radical Cystectomy: Risk Assessment of Intraoperative Frozen Section.
    Urol Int. 2022;106:816-824.
    PubMed     Abstract available
    
    
    
50. DREGER NM, Lohbeck A, Roth S, Godde D, et al
    Effectiveness and Safety of a Modified Technique of Transvesical Obturator Nerve Block to Avoid Adductor Contractions during Transurethral Resection of Bladder Tumors.
    Urol Int. 2022;106:775-783.
    PubMed     Abstract available
    
    
    
51. SCHNEIDEWIND L, Torabi L, Drager DL, Hakenberg OW, et al
    Reduction of Perioperative Antibiotic Prophylaxis in Open Radical Cystectomy with Ileal Conduit Is Feasible: Results of a Prospective Clinical Trial.
    Urol Int. 2022;106:825-831.
    PubMed     Abstract available
    
    
    
52. CILESIZ NC, Ozkan A, Kalkanli A, Gezmis CT, et al
    Spinal Anesthesia Provides Longer Administration Time for Postoperative Intravesical Chemotherapy after TUR-B Operation.
    Urol Int. 2022;106:768-774.
    PubMed     Abstract available
    
    
    December 2021
53. ZAZZARA M, Nazaraj A, Scarcia M, Cardo G, et al
    Electromotive Drug Administration of Mitomycin C (EMDA/MMC) versus Intravesical Immunotherapy with Bacillus Calmette-Guerin (BCG) in Intermediate and High Risk Non Muscle Invasive Bladder Cancer.
    Urol Int. 2021 Dec 21:1-8. doi: 10.1159/000520630.
    PubMed     Abstract available
    
    
    November 2021
54. PULLEN L, Kaspar C, Panic A, Hess J, et al
    Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer: A Retrospective Analysis of a Single-Centre Cohort.
    Urol Int. 2021 Nov 10:1-6. doi: 10.1159/000519898.
    PubMed     Abstract available
    
    
    October 2021
55. WANG Y, Qu H, Xu B, Wu J, et al
    Expression of FOXA1 Is Associated with the Tumor-Infiltrating M2 Macrophage, Cytotoxic T Lymphocyte, and Effect of Chemotherapy in Bladder Cancer.
    Urol Int. 2021 Oct 27:1-6. doi: 10.1159/000519129.
    PubMed     Abstract available
    
    
    
56. SU Q, Gao S, Lu C, Wu X, et al
    Comparing Prognosis Associated with Partial Cystectomy and Trimodal Therapy for Muscle-Invasive Bladder Cancer Patients.
    Urol Int. 2021 Oct 14:1-12. doi: 10.1159/000518562.
    PubMed     Abstract available
    
    
    August 2021
57. STRUCK JP, Hennig MJP, Hupe MC, Moharam N, et al
    Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational Survey.
    Urol Int. 2021 Aug 31:1-11. doi: 10.1159/000518166.
    PubMed     Abstract available
    
    
    
58. RUCKHER J, Lobitz J, Follmann M, Derenz S, et al
    Guideline-Based Quality Indicators for Kidney and Bladder Cancer in Germany: Development and Implementation.
    Urol Int. 2021 Aug 12:1-8. doi: 10.1159/000517893.
    PubMed     Abstract available
    
    
    
59. TOHI Y, Miyauchi Y, Yamasaki M, Fujiwara K, et al
    Incidental Bladder Cancer Found on Cystoscopy during Prostate Biopsy: Prevalence, Pathological Findings, and Oncological Outcome.
    Urol Int. 2021 Aug 5:1-7. doi: 10.1159/000517895.
    PubMed     Abstract available
    
    
    
60. RAVENTOS BUSQUETS CX, Semidey ME, Lozano Palacio F, Carrion Puig A, et al
    Is Tumor Budding a New Predictor for Early Cystectomy in pT1 High-Grade Bladder Cancer?
    Urol Int. 2021 Aug 5:1-9. doi: 10.1159/000517543.
    PubMed     Abstract available
    
    
    June 2021
61. GAO T, Ji Y
    Long Noncoding RNA LINC00707 Accelerates Tumorigenesis and Progression of Bladder Cancer via Targeting miR-145/CDCA3 Regulatory Loop.
    Urol Int. 2021 Jun 30:1-15. doi: 10.1159/000514388.
    PubMed     Abstract available
    
    
    March 2021
62. CHEN P, Chen J, He L, Du C, et al
    Identification of circRNA-miRNA-mRNA Regulatory Network in Bladder Cancer by Integrated Analysis.
    Urol Int. 2021 Mar 31:1-11. doi: 10.1159/000512066.
    PubMed     Abstract available
    
    
    
63. LIU Y, Huang X, Guo L, Luo N, et al
    LINC00649 Facilitates the Cellular Process of Bladder Cancer Cells via Signaling Axis miR-16-5p/JARID2.
    Urol Int. 2021 Mar 31:1-9. doi: 10.1159/000506239.
    PubMed     Abstract available
    
    
    
64. LIU Z, Zhang Y, Sun G, Ouyang W, et al
    Comparison of Thulium Laser Resection of Bladder Tumors and Conventional Transurethral Resection of Bladder Tumors for Non-Muscle-Invasive Bladder Cancer.
    Urol Int. 2021 Mar 30:1-6. doi: 10.1159/000514042.
    PubMed     Abstract available
    
    
    February 2021
65. YANG X, Zhuang J, Yu H, Cao Q, et al
    Effect of Coronavirus Disease 2019 on Patients with Bladder Cancer in China.
    Urol Int. 2021 Feb 24:1-3. doi: 10.1159/000512895.
    PubMed    
    
    
    January 2021
66. KAYNAR M, Celik ZE, Altintas E, Batur AF, et al
    Comparison of Two Different Bipolar Energy Resources in Transurethral Resection of Bladder Tumors.
    Urol Int. 2021;105.
    PubMed     Abstract available
    
    
    
67. IZOL V, Deger M, Ozden E, Bolat D, et al
    The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.
    Urol Int. 2021;105.
    PubMed     Abstract available
    
    
    
68. YANG C, Lv Z, Li Y
    Reduction of Bladder Volume after BCG Immunotherapy.
    Urol Int. 2021;105.
    PubMed     Abstract available
    
    
    December 2020
69. RABER M, Buchholz N, Vercesi A, Hendawi NA, et al
    Treatment of Large Non-Muscle-Invasive Bladder Cancer: The Potential Role of Neoadjuvant Intravesical Chemotherapy.
    Urol Int. 2020 Dec 17:1-6. doi: 10.1159/000512052.
    PubMed     Abstract available
    
    
    January 2020
70. SUZUKI K, Hinata N, Inoue TA, Nakamura I, et al
    Comparison of the Perioperative and Postoperative Outcomes of Ileal Conduit and Cutaneous Ureterostomy: A Propensity Score-Matched Analysis.
    Urol Int. 2020;104.
    PubMed     Abstract available
    
    
    
71. POLETAJEW S, Krajewski W, Adamowicz J, Kolodziej A, et al
    Management of Intradiverticular Bladder Tumours: A Systematic Review.
    Urol Int. 2020;104.
    PubMed     Abstract available
    
    
    
72. JOKISCH JF, Grimm T, Buchner A, Kretschmer A, et al
    Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological Outcome.
    Urol Int. 2020;104.
    PubMed     Abstract available
    
    
    
73. ZHU C, Deng Z, Yuan L, Su J, et al
    Transurethral-Assisted Transumbilical Laparoendoscopic Single-Site Radical Cystectomy: Initial Short-Term Experience.
    Urol Int. 2020;104.
    PubMed     Abstract available
    
    
    
74. SARIER M, Sepin N, Keles Y, Imir L, et al
    Is There any Association between Urothelial Carcinoma of the Bladder and Human Papillomavirus? A Case-Control Study.
    Urol Int. 2020;104.
    PubMed     Abstract available
    
    
    
75. FROEHNER M, Koch R, Heberling U, Borkowetz A, et al
    Validation of a Questionnaire-Suitable Comorbidity Index in Patients Undergoing Radical Cystectomy.
    Urol Int. 2020;104.
    PubMed     Abstract available
    
    
    
76. FEDELI U, De Paoli A, Corti MC, Cacciamani GE, et al
    Perioperative Mortality and Long-Term Survival after Radical Cystectomy: A Population-Based Study in a Southern European Country on 4,389 Patients.
    Urol Int. 2020;104.
    PubMed     Abstract available
    
    
    
77. TAMALUNAS A, Buchner A, Kretschmer A, Jokisch F, et al
    Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up.
    Urol Int. 2020;104.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.